• Selected 2006 Public Offerings and Rule 144A Placements
• Selected 2006 M&A Transactions
• Selected 2006 Venture Financings As Company Counsel
• Selected 2006 Strategic Alliances, Joint Venture and Licensing Transactions
• Selected 2006 Information Technology Transactions
• Selected 2006 Life Sciences Transactions

Selected 2006 Public Offerings and Rule 144A Placements (PDF Version)

• Achillion Pharmaceuticals — Initial Public Offering of Common Stock — $59,512,500 — Counsel to Issuer
• Acme Packet — Initial Public Offering of Common Stock — $116,584,000 — Counsel to Underwriters
• Alexion Pharmaceuticals — Public Offering of Common Stock — $148,350,000 — Counsel to Underwriters
• Alnylam Pharmaceuticals — Public Offerings of Common Stock — $165,917,000 — Counsel to Issuer
• Altus Pharmaceuticals — Initial Public Offering of Common Stock — $120,750,000 — Counsel to Underwriters
• CapitalSource — Public Offering of Common Stock — $414,000,000 — Counsel to Underwriters
• Ciena — Public Offering of 0.25% Convertible Senior Notes due 2013 — $300,000,000 — Counsel to Underwriters
• CIGNA — Public Offering of 6.150% Senior Notes due 2036 — $250,000,000 — Counsel to Issuer
• CIT Group — Public Offerings of Medium-Term Notes — $16,350,216,000 — Counsel to Underwriters and Agents
• CollaGenex Pharmaceuticals — Public Offering of Common Stock — $45,500,000 — Counsel to Issuer
• Corporación Andina de Fomento — Public Offering of 5.75% Notes Due 2017 — $250,000,000 — Counsel to Underwriters
• CTC Media — Initial Public Offering of Common Stock — $380,525,000 — Counsel to Issuer
• Cubist Pharmaceuticals — Public Offering of 2.25% Convertible Subordinated Notes due 2013 — $350,000,000 — Counsel to Underwriters
• Dean Foods — Public Offering of 7.000% Senior Notes due 2016 — $500,000,000 — Counsel to Issuer
• Emergent BioSolutions — Initial Public Offering of Common Stock — $62,500,000 — Counsel to Issuer
• Evercore Partners — Initial Public Offering of Common Stock — $95,392,500 — Counsel to Underwriters
• Globalstar — Initial Public Offering of Common Stock — $146,625,000 — Regulatory Counsel to Issuer
• GTx — Public Offering of Common Stock — $60,793,600 — Counsel to Underwriters
• Labopharm — Initial Public Offering of Common Stock — $101,200,000 — Counsel to Underwriters
• LeMaitre Vascular — Initial Public Offering of Common Stock — $38,500,000 — Counsel to Underwriters
• MBB Industries — Initial Public Offering of Common Stock — €17,480,000 — Counsel to Issuer
• Medtronic — Rule 144A Placement of 1.50% Convertible Senior Notes due 2011 and 1.625% Convertible Senior Notes due 2013 — $4,400,000,000 — Counsel to Issuer
• Millennium Pharmaceuticals — Public Offering of 2.25% Convertible Senior Notes due 2011 — $250,000,000 — Counsel to Issuer
• NitroMed — Public Offering of Common Stock — $62,504,500 — Counsel to Issuer
• NxStage Medical — Public Offering of Common Stock — $56,336,000 — Counsel to Issuer
• Optos — Initial Public Offering of Ordinary Shares — £50,000,000 — Counsel to Issuer
• PS Business Parks — Public Offerings of Preferred Stock — $94,600,000 — Counsel to Underwriters
• SS&C Technologies — Exchange Offer for 11 3/4% Senior Subordinated Notes due 2013 — $205,000,000 — Counsel to Issuer
• Speedel — Public Offering of Common Stock — CHF 96,541,500 — Counsel to Issuer
• Targacept — Initial Public Offering of Common Stock — $45,000,000 — Counsel to Underwriters
• Temenos Group — Public Offering of 1.5% Convertible Bonds due 2013 — CHF 132,500,000 — Counsel to Issuer
• Visicu — Initial Public Offering of Common Stock — $110,400,000 — Counsel to Underwriters
• Watts Water Technologies — Public Offering of Common Stock — $230,000,000 — Counsel to Issuer
• World Energy Solutions — Initial Public Offering of Common Stock — $25,525,000 — Counsel to Issuer

Selected 2006 M&A Transactions (PDF Version)

• Akamai Technologies — acquisition of Nine Systems — $160,000,000
• Arlington Tankers — asset acquisition from Stena Group — $92,000,000
• Becton Dickinson — acquisition of GeneOhm Sciences — $230,000,000
• Blackstone — sale of Kabel BW to EQT — undisclosed
• BrassRing — acquisition by Kenexa — $115,000,000
• Danaher — acquisition of Sybron Dental Specialties — $2,200,000,000 (co-counsel)
• Domantis — acquisition by GSK — £230,000,000
• GeoTrust — acquisition by VeriSign — $125,000,000
• GlycoFi — acquisition by Merck — $400,000,000
• HMS Holdings — acquisition of the Benefits Solutions Practice Area division of Public Consulting Group — $100,000,000
• IDEXX Laboratories — acquisition of Osmetech's Critical Care Division — $44,900,000*
• IDX Systems — acquisition by GE Healthcare — $1,200,000,000
• I-Logix — acquisition by Telelogic — $80,000,000
• IMlogic — acquisition by Symantec — $90,000,000
• Infinity Pharmaceuticals — acquisition of Discovery Partners — $162,500,000
• Kronos — acquisition of Unicru — $150,000,000
• Lifeline Systems — acquisition by Philips Electronics — $750,000,000
• Linde — acquisition of BOC Group — $14,800,000,000 (worldwide antitrust counsel)
• Lucent — merger with Alcatel — $13,000,000,000 (US CFIUS counsel and worldwide antitrust co-counsel)
• MatrixOne — acquisition by Dassault Systèmes — $408,000,000
• PAREXEL International — acquisition of California Clinical Trials Medical Group and Behavioral and Medical Research — $65,000,000
• PepsiCo — acquisition of Stacy's Pita Chip Company — undisclosed
• Red Hat — acquisition of JBoss — $420,000,000 (including earnout)
• RSA Security — acquisition by EMC — $2,300,000,000
• Savient Pharmaceuticals — sale of oral liquid pharmaceuticals business to Close Brothers Private Equity — $176,000,000
• SkillSoft — acquisition of NETg from Thomson — $285,000,000*
• Softricity — acquisition by Microsoft — undisclosed
• Thermo Fisher Scientific — acquisition of Cohesive Technologies — undisclosed
• Verizon Communications — acquisition of MCI — $8,500,000,000 (regulatory counsel)
• WebMD — acquisition of Subimo — $60,000,000
• WiderThan — acquisition by RealNetworks — $350,000,000

Selected 2006 Venture Financings As Company Counsel (PDF Version)

• Acopia Networks — $20,000,000
• Adnexus Therapeutics — $27,000,000
• Airwide Solutions — $25,000,000
• Akorri — $15,000,000
• A123 Systems — $30,000,000
• Archivas — $12,000,000
• Aushon BioSystems — $7,800,000
• Axsun Technologies — $15,000,000
• BlueNote Networks — $15,000,000
• Codon Devices — $20,000,000
• Egenera — $26,000,000
• Gigle Semiconductor — $11,000,000
• GloNav — $16,200,000
• Icera — $40,000,000
• IGA Worldwide — $17,000,000
• Incipient — $24,000,000
• IntelliVid — $8,000,000
• Intercept Pharmaceuticals — $41,000,000
• Mintera — $10,000,000
• NanoNexus — $32,000,000
• Njini — $13,000,000
• Partsearch Technologies — $10,750,000
• Pivot Solutions — $8,000,000
• Reflexis Systems — $10,000,000
• Scanbuy — $9,000,000
• SiCortex — $21,000,000
• SmartBargains — $10,000,000
• SupplyScape — $8,000,000
• Tetraphase Pharmaceuticals — $25,000,000
• Transitive — $12,250,000
• TransMedics — $29,750,000
• Ubiquisys — $12,000,000
• U3 Pharma — €27,000,000
• WeeWorld — $15,500,000
• Xanthus Pharmaceuticals — $25,000,000
• Zipcar — $25,000,000
• Zopa — $15,000,000

Selected 2006 Strategic Alliances, Joint Venture and Licensing Transactions (PDF Version)

• Airwide Solutions — US and international reseller and sales agreements
• Alantos Pharmaceuticals — Collaboration with Servier for oral administration treatment for type 2 diabetes
• Alnylam Pharmaceuticals — Collaboration with Novartis Institutes for BioMedical Research to develop RNAi therapeutics for pandemic flu
• Applix — International software solution partner agreement
• AVEO Pharmaceuticals — License from Kirin Brewery of clinical-stage cancer product
• Avid — Key licensing, distribution and supply agreements for Avid Technology and its Digidesign division
• Bose — Various licensing and collaboration matters
• Braintree Laboratories — License to Schering-Plough of MiraLAX® over-the-counter gastrointestinal products
• Broadcom — Licenses in connection with various acquisitions
• Brooks Automation — Formation of Japanese joint venture with Yaskawa Electric
• Cephalon — Licensing advice in connection with settlements of Provigil® generic patent infringement litigation
• Constant Contact — Various co-promotion and licensing matters
• Emergent BioSolutions — Supply agreements for a therapeutic anthrax immune globulin product
• From the Top — Agreements with WGBH, Carnegie Hall and others for production of public television series
• Idera Pharmaceuticals — Collaboration with Merck to develop vaccines incorporating toll-like receptor agonists
• IETF — Advice to the leading standards body for the Internet
• IGA Worldwide — Online game advertising agreement with Electronic Arts
• Infinity Pharmaceuticals — Alliance with MedImmune for novel small molecule cancer drugs
• Momenta Pharmaceuticals — Alliance with Sandoz to develop complex generic and follow-on biotechnology drugs
• Palm — Various patent licenses
• Panera Bread — Licensing and supply arrangements for Canadian retail expansion
• PTC Therapeutics — Collaboration with Schering-Plough for the development of hepatitis C virus drugs
• ReGen Therapeutics — Distribution and marketing of nutraceutical compounds through Metagenics
• SiCortex — Various development, manufacturing, services and distribution agreements
• Silicon Integration Initiative — Formation of low-power integrated circuit design flow coalition
• Starent Networks — International distribution agreements and licensing transactions
• Sucampo Pharmaceuticals — Licensing advice in connection with corporate reorganization
• Syntonix Pharmaceuticals — Strategic alliance with Biovitrum for long-acting hemophilia B product
• Xanthus — Acquisition from Schering AG of rights to clinical-stage cancer compounds
• Ziopharm — Acquisition from Baxter Healthcare of clinical-stage anti-cancer agent program

Selected 2006 Information Technology Transactions (PDF Version)

Venture Capital Financings

• Acopia Networks — $20,000,000
• Airwide Solutions — $25,000,000
• Axsun Technologies — $15,000,000
• BlueNote Networks — $15,000,000
• Egenera — $26,000,000
• Icera — $40,000,000
• Incipient — $24,000,000
• NanoNexus — $32,000,000
• Reflexis Systems — $10,000,000
• SiCortex — $21,000,000
• SmartBargains — $10,000,000

Licensing, Outsourcing and Alliances

• Applix — International software solution partner agreement
• Avid — Key licensing, distribution and supply agreements for Avid Technology and its Digidesign division
• Bose — Various licensing and collaboration matters
• Broadcom — Licenses in connection with various acquisitions
• Constant Contact — Various co-promotion and licensing matters
• Columbia University — Advice regarding open source and proprietary software licensing
• IETF — Advice to the leading standards body for the Internet
• IGA Worldwide — Online game advertising agreement with Electronic Arts
• Palm — Various patent licenses
• Starent Networks — International distribution agreements and licensing transactions
• State Street — Outsourcing of financial services functions for major mutual funds and institutions

Public Offerings and Rule 144A Placements

• Acme Packet — Initial Public Offering of Common Stock — $116,584,000 — Counsel to Underwriters
• Ciena — Public Offering of 0.25% Convertible Senior Notes due 2013 — $300,000,000 — Counsel to Underwriters
• Globalstar — Initial Public Offering of Common Stock — $146,625,000 — Regulatory Counsel to Issuer
• Medtronic — Rule 144A Placement of 1.50% Convertible Senior Notes due 2011 and 1.625% Convertible Senior Notes due 2013 — $4,400,000,000 — Counsel to Issuer
• Optos — Initial Public Offering of Ordinary Shares — £50,000,000 — Counsel to Issuer
• SS&C Technologies — Exchange Offer for 11 3/4% Senior Subordinated Notes due 2013 — $205,000,000 — Counsel to Issuer
• Temenos Group — Public Offering of 1.5% Convertible Bonds due 2013 — CHF 132,500,000 — Counsel to Issuer
• Watts Water Technologies — Public Offering of Common Stock — $230,000,000 — Counsel to Issuer
• World Energy Solutions — Initial Public Offering of Common Stock — $25,525,000 — Counsel to Issuer

Mergers and Acquisitions

• Akamai Technologies — acquisition of Nine Systems — $160,000,000
• Blackboard — acquisition of WebCT — $180,000,000
• Danaher — acquisition of Sybron Dental Specialties — $2,200,000,000 (co-counsel)
• Kronos — acquisition of Unicru — $150,000,000
• IMlogic — acquisition by Symantec — $90,000,000
• MatrixOne — acquisition by Dassault Systèmes — $408,000,000
• Red Hat — acquisition of JBoss — $420,000,000 (including earnout)
• RSA Security — acquisition by EMC — $2,300,000,000
• SkillSoft — acquisition of NETg from Thomson — $285,000,000*
• WebMD — acquisition of Subimo — $60,000,000
• WiderThan — acquisition by RealNetworks — $350,000,000

Selected 2006 Life Sciences Transactions (PDF Version)

Venture Capital and PIPEs Financings

• Adnexus Therapeutics — $27,000,00
• Aushon BioSystems — $7,800,000
• BioSphere Medical — $14,525,000
• Codon Devices — $20,000,000
• Intercept Pharmaceuticals — $41,000,000
• Tetraphase Pharmaceuticals — $25,000,000
• TransMedics — $29,750,000
• U3 Pharma — €27,000,000
• Xanthus Pharmaceuticals — $25,000,000

Strategic Alliances and Collaborations

• AVEO Pharmaceuticals — License from Kirin Brewery of clinical-stage cancer product
• Braintree Laboratories — License to Schering-Plough of MiraLAX® over-the-counter gastrointestinal products
• Bristol-Myers Squibb — Licensing advice for drug discovery and development agreements
• Cephalon — Licensing advice in connection with settlements of Provigil® generic patent infringement litigation
• Idera Pharmaceuticals — Collaboration with Merck to develop vaccines incorporating toll-like receptor agonists
• Infinity Pharmaceuticals — Alliance with MedImmune for novel small molecule cancer drugs
• Momenta Pharmaceuticals — Alliance with Sandoz to develop complex generic and follow-on biotechnology drugs
• Novartis — License by Novartis Pharma to Cerimon of Simulect® antibody for treatment of inflammatory bowel disease
• PTC Therapeutics — Collaboration with Schering-Plough for the development of hepatitis C virus drugs
• Syntonix Pharmaceuticals — Strategic alliance with Biovitrum for long-acting hemophilia B product
• Ziopharm Oncology — Acquisition from Baxter Healthcare of clinical-stage anti-cancer agent program

Public Offerings and Rule 144A Placements

• Achillion Pharmaceuticals — Initial Public Offering of Common Stock — $59,512,500 — Counsel to Issuer
• Alexion Pharmaceuticals — Public Offering of Common Stock — $148,350,000 — Counsel to Underwriters
• Alnylam Pharmaceuticals — Public Offerings of Common Stock — $165,917,000 — Counsel to Issuer
• Altus Pharmaceuticals — Initial Public Offering of Common Stock — $120,750,000 — Counsel to Underwriters
• CollaGenex Pharmaceuticals — Public Offering of Common Stock — $45,500,000 — Counsel to Issuer
• Emergent BioSolutions — Initial Public Offering of Common Stock — $62,500,000 — Counsel to Issuer
• Labopharm — Initial Public Offering of Common Stock — $101,200,000 — Counsel to Underwriters
• LeMaitre Vascular — Initial Public Offering of Common Stock — $38,500,000 — Counsel to Underwriters
• Medtronic — Rule 144A Placement of 1.50% Convertible Senior Notes due 2011 and 1.625% Convertible Senior Notes due 2013 — $4,400,000,000 — Counsel to Issuer
• Millennium Pharmaceuticals — Public Offering of 2.25% Convertible Senior Notes due 2011 — $250,000,000 — Counsel to Issuer
• NxStage Medical — Public Offering of Common Stock — $56,336,000 — Counsel to Issuer

Mergers and Acquisitions

• Becton Dickinson — Acquisition of GeneOhm Sciences — $230,000,000
• Domantis — Acquisition by GSK — £230,000,000
• GlycoFi — Acquisition by Merck — $400,000,000
• HMS Holdings — Acquisition of the Benefits Solutions Practice Area division of Public Consulting Group — $100,000,000
• IDX Systems — Acquisition by GE Healthcare — $1,200,000,000
• Infinity Pharmaceuticals — Acquisition of Discovery Partners — $162,500,000
• Lifeline Systems — Acquisition by Philips Electronics — $750,000,000
• PAREXEL International — Acquisition of California Clinical Trials Medical Group and Behavioral and Medical Research — $65,000,000
• Savient Pharmaceuticals — Sale of oral liquid pharmaceuticals business to Close Brothers Private Equity — $176,000,000
• Thermo Fisher Scientific — Acquisition of Cohesive Technologies — undisclosed
• WebMD — Acquisition of Subimo — $60,000,000

*pending